NgR Antibodies

Santa Cruz Biotechnology provides a broad selection of NgR Antibodies for studying Nogo receptor (NgR) proteins through various research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nogo receptor plays a critical role in the central nervous system by mediating the inhibitory effects of myelin on axonal regeneration. NgR is involved in processes such as neuronal signaling and plasticity, making it a significant target for research in neurodegenerative diseases and injury recovery. Understanding NgR function is essential for developing therapeutic strategies aimed at promoting nerve regeneration and improving outcomes in neurological disorders. NgR research has revealed important insights into axon growth regulation and neural repair mechanisms. Ongoing studies of NgR continue to uncover new aspects of its role in neurological development and disease progression. Current research focuses on how NgR influences neural circuit formation and maintenance throughout different life stages. Santa Cruz Biotechnology monoclonal antibodies for NgR support researchers worldwide in advancing neuroscience and developing potential treatments for neurological conditions.